Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03550937
Other study ID # 201310064RINA
Secondary ID
Status Completed
Phase
First received
Last updated
Start date December 11, 2013
Est. completion date February 6, 2018

Study information

Verified date May 2018
Source National Taiwan University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Rotavirus remains among the leading causes of pediatric gastroenteritis requiring hospitalization in the world. Surveillance studies revealed that more than 90% of the global circulating rotavirus strains were predominated by several major genotypes. Clinical trials and post-marketing studies have demonstrated that the currently available rotavirus vaccine can provide sufficient protection against strains of the prevalent genotypes. However, the emerging strains with new genotypes were increasingly reported in the past decade, an ongoing surveillance of the strain changes is needed in the regions where the pediatric population is either fully or partly immunized. In this project, the investigators will setup a hospital-based gastroenteritis surveillance network by incorporating 8 major hospitals in northern, central, southern and eastern Taiwan. From 2013 to 2015, children aged 5 years or younger hospitalized to one of the 8 sentinel hospitals due to acute gastroenteritis will be screened for rotavirus infection, and viral proteins 7 [VP7] (G type) and viral proteins 4 [VP4] (P type) genotypes of rotavirus will be determined for each infected case. The demographics and clinical manifestations of study subjects will also be collected and analyzed. Through this project, the investigators will be able to detect emerging genotypes of rotavirus and delineate the strain distribution during the two years of study in Taiwan. The investigators can also have more comprehensive understanding of the epidemiology of rotavirus regarding to the incidence, disease characteristics, temporal and geographic variations of severe rotavirus gastroenteritis in Taiwanese children. Results from this project will provide valuable information for future implementation of mass immunization against rotavirus in Taiwan.


Recruitment information / eligibility

Status Completed
Enrollment 5040
Est. completion date February 6, 2018
Est. primary completion date February 6, 2018
Accepts healthy volunteers No
Gender All
Age group N/A to 5 Years
Eligibility Inclusion Criteria:

- aged less than 60 months,

- hospitalized in 1 of the 8 hospitals,

- having diarrhea not caused by any known underlying diseases.

Exclusion Criteria:

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Taiwan Chang Bing Show Chwan Memorial Hospital Chang Hua
Taiwan Chang Hua Show Chwan Memorial Hospital Chang Hua
Taiwan National Taiwan University Hospital Yun-Lin Branch Douliu
Taiwan Buddhist Tzu Chi General Hospital, Hualien Tzu Chi Medical Center Hualien City
Taiwan Kaohsiung Chang Gung Memorial Hospital Kaohsiung
Taiwan China Medical University Hospital Taichung
Taiwan National Cheng Kung University Hospital Tainan
Taiwan Mackay Memorial Hospital Taipei
Taiwan National Taiwan University Hospital Taipei
Taiwan Chang Gung Children's Hospital Taoyuan

Sponsors (1)

Lead Sponsor Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary monitor the strain diversity of rotavirus in Taiwan monitor the strain diversity of rotavirus in Taiwan, including the individual serotype prevalence and emerging genotypes 4 years